What is Aviceda Therapeutics worth?
$346.5Mlast known valuation
Aviceda Therapeutics last raised $75.0M in its Later Stage VC (Nov 2024).
Free account
See the evidence behind this price
- ·Post-money valuations for all 3 rounds
- ·The complete investor list — 13 names
- ·Watchlist + deal alerts for Aviceda Therapeutics
Create free account
No card required
Funding history
3 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Nov 2024 | Later Stage VC | $75.0M | ▮ | ▮ |
| May 2024 | Early Stage VC | $18.9M | ▮ | ▮ |
| May 2023 | Early Stage VC | $15.6M | ▮ | ▮ |
How Aviceda Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Aviceda Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Aviceda Therapeutics worth?
- Aviceda Therapeutics's last known valuation is $346.5M.
- How much has Aviceda Therapeutics raised?
- Aviceda Therapeutics has raised $276.3M in total funding across 3 recorded rounds.
- When did Aviceda Therapeutics last raise?
- Aviceda Therapeutics last raised in Nov 2024 (Later Stage VC), raising $75.0M.